Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma

Biomedicine and Pharmacotherapy

Volumn 68, Issue 4, 2014, Pages 401-407

  Zhang, Li ^a   Zhou, Xue Feng ^a   Pan, Gao Feng ^a   Zhao, Jin Ping ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Long non coding RNAs; Lung adenocarcinoma; Migration and invasion; SiRNA; ZXF1

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; LONG UNTRANSLATED RNA; SMALL INTERFERING RNA;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; ZXF1 GENE; ADENOCARCINOMA; CELL MOTION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR CELL LINE;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, SMALL INTERFERING; SURVIVAL RATE; UP-REGULATION;

EID: 84901607842     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.03.001     Document Type: Article

References (36)

1. Chou H.C., Chan H.L. Effect of glutathione reductase knockdown in response to UVB-induced oxidative stress in human lung adenocarcinoma. Proteome Sci 2014, 12(1):2.
2. Pilotto S., Bria E., Peretti U., Massari F., Garassino M., Pelosi G., et al. Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with Concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number. J Thorac Oncol 2013, 8(12):e105-e106.
3. Menna C., De Falco E., Pacini L., Scafetta G., Ruggieri P., Puca R., et al. Axitinib affects cell viability and migration of a primary foetal lung adenocarcinoma culture. Cancer Invest 2014, 32(1):13-21.
4. Fang W., Zhang J., Liang W., Huang Y., Yan Y., Wu X., et al. Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for Chinese patients with squamous cell carcinoma of lung harboring EGFR mutation. J Thorac Dis 2013, 5(5):585-592.
5. Shimada Y., Saji H., Nomura M., Matsubayashi J., Yoshida K., Kakihana M., et al. Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification. Onco Targets Ther 2013, 6:1597-1604.
6. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012, 81:145-166.
7. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136(4):629-641.
8. Nacher J.C. Community structure of non-coding RNA interaction network. J Integr Bioinform 2013, 10(2):217.
9. Du Toit A., Non-coding RNA: RNA stability control by Pol II. Nat Rev Mol Cell Biol 2013, 14(3):128.
10. Pasmant E., Sabbagh A., Masliah-Planchon J., Ortonne N., Laurendeau I., Melin L., et al. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J Natl Cancer Inst 2011, 103(22):1713-1722.
11. Pasmant E., Laurendeau I., Heron D., Vidaud M., Vidaud D., Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 2007, 67(8):3963-3969.
12. Congrains A., Kamide K., Ohishi M., Rakugi H. ANRIL: molecular mechanisms and implications in human health. Int J Mol Sci 2013, 14(1):1278-1292.
13. Silva J.M., Boczek N.J., Berres M.W., Ma X., Smith D.I. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol 2011, 8(3):496-505.
14. Tano K., Mizuno R., Okada T., Rakwal R., Shibato J., Masuo Y., et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010, 584(22):4575-4580.
15. Ying L., Chen Q., Wang Y., Zhou Z., Huang Y., Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 2012, 8(9):2289-2294.
16. Lai M.C., Yang Z., Zhou L., Zhu Q.Q., Xie H.Y., Zhang F., et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012, 29(3):1810-1816.
17. Ji P., Diederichs S., Wang W., Böing S., Metzger R., Schneider P.M., et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22(39):8031-8041.
18. Eißmann M., Gutschner T., Hämmerle M., Günther S., Caudron-Herger M., Groß M., et al. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol 2012, 9(8):1076-1087.
19. Wang X.F., Zhao Y.B., Wu Q., Sun Z.H., Li H.J. Triptolide induces apoptosis in endometrial cancer via a p53-independent mitochondrial pathway. Mol Med Rep 2014, 9(1):39-44.
20. Ding Y., He D., Florentin D., Frolov A., Hilsenbeck S., Ittmann M., et al. Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res 2013, 19(22):6101-6111.
21. Huang W., Long N., Khatib H. Genome-wide identification and initial characterization of bovine long non-coding RNAs from EST data. Anim Genet 2012, 43(6):674-682.
22. Sørensen K.P., Thomassen M., Tan Q., Bak M., Cold S., Burton M., et al. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat 2013, 142(3):529-536.
23. Chen F.J., Sun M., Li S.Q., Wu Q.Q., Ji L., Liu Z.L., et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog 2013, 52(11):908-915.
24. Liu X.H., Liu Z.L., Sun M., Liu J., Wang Z.X., De W. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 2013, 13:464.
25. Ren S., Liu Y., Xu W., Sun Y., Lu J., Wang F., et al. Long non-coding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol 2013, 190(6):2278-2287.
26. Gutschner T., Hämmerle M., Eissmann M., Hsu J., Kim Y., Hung G., et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013, 73(3):1180-1189.
27. Monnier P., Martinet C., Pontis J., Stancheva I., Ait-Si-Ali S., Dandolo L. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proc Natl Acad Sci U S A 2013, 110(51):20693-20698.
28. Du Y., Kong G., You X., Zhang S., Zhang T., Gao Y., et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem 2012, 287(31):26302-26311.
29. Lu K.H., Li W., Liu X.H., Sun M., Zhang M.L., Wu W.Q., et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer 2013, 13:461.
30. Kondrashov A.V., Kiefmann M., Ebnet K., Khanam T., Muddashetty R.S., Brosius J. Inhibitory effect of naked neural BC1 RNA or BC200 RNA on eukaryotic in vitro translation systems is reversed by poly(A)-binding protein (PABP). J Mol Biol 2005, 353(1):88-103.
31. Lee H.W., Park Y.M., Lee S.J., Cho H.J., Kim D.H., Lee J.I., et al. Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma. Clin Cancer Res 2013, 19(21):5879-5889.
32. Rumora A.E., Wang S.X., Ferris L.A., Everse S.J., Kelm R.J. Structural basis of multisite single-stranded DNA recognition and ACTA2 repression by purine-rich element binding protein B (Purβ). Biochemistry 2013, 52(26):4439-4450.
33. Han M., Wang Y., Liu M., Bi X., Bao J., Zeng N., et al. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells. Cancer Sci 2012, 103(6):1058-1064.
34. Roy S., Garg V. Alpha smooth muscle actin expression in a case of ameloblastic carcinoma: a case report. J Oral Maxillofac Res 2013, 4(1):e4.
35. Wan Y.G., Che X.Y., Sun W., Huang Y.R., Meng X.J., Chen H.L., et al. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo. J Ethnopharmacol 2013, [pii: S0378-8741(13)00868-4].
36. Lin G., Sun L., Wang R., Guo Y., Xie C. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer. J Thorac Oncol 2014, 9(2):170-178.